Procalcitonin: Potential role in diagnosis and management of sepsis

Advances in Clinical Chemistry

Volumn 68, Issue , 2015, Pages 71-86

  Rowland, Tim ^a   Hilliard, Heather ^b   Barlow, Gavin ^c  

^a Strang Douglas   (United Kingdom)

^b HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^c CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Antibiotic stewardship; Biomarkers; Procalcitonin; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

BLOOD; HUMAN; INTENSIVE CARE; PROGNOSIS; SEPSIS;

ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CALCITONIN; CRITICAL CARE; HUMANS; PROGNOSIS; PROTEIN PRECURSORS; SEPSIS;

EID: 84922119647     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.acc.2014.11.005     Document Type: Chapter

References (47)

1. Angus D.C., van der Poll T. Severe sepsis and septic shock. N. Engl. J. Med. 2013, 369(9):840-851.
2. Lever A., Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ 2007, 335(7625):879-883.
3. Gaieski D.F., Edwards J.M., Kallan M.J., Carr B.G. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit. Care Med. 2013, 41(5):1167-1174.
4. Adhikari N.K., Fowler R.A., Bhagwanjee S., Rubenfeld G.D. Critical care and the global burden of critical illness in adults. Lancet 2010, 376(9749):1339-1346.
5. Kissoon N., Carcillo J.A., Espinosa V., Argent A., Devictor D., Madden M., et al. World Federation of Pediatric Intensive Care and Critical Care Societies: Global Sepsis Initiative. Pediatr. Crit. Care Med. 2011, 12(5):494-503.
6. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit. Care Med. 2013, 41(2):580-637.
7. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341(8844):515-518.
8. Jin M., Khan A. Procalcitonin: uses in the clinical laboratory for the diagnosis of sepsis. LabMedicine 2010, 41(3):173-177.
9. Becker K.L., Snider R., Nylen E.S. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br. J. Pharmacol. 2010, 159(2):253-264.
10. Povoa P., Salluh J.I. Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review. Ann. Intensive Care 2012, 2(1):32.
11. Simon L., Gauvin F., Amre D.K., Saint-Louis P., Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin. Infect. Dis. 2004, 39(2):206-217.
12. Tang B.M., Eslick G.D., Craig J.C., McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect. Dis. 2007, 7(3):210-217.
13. Wacker C., Prkno A., Brunkhorst F.M., Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect. Dis. 2013, 13(5):426-435.
14. Schuetz P., Müller B., Christ-Crain M., Stolz D., Tamm M., Bouadma L., et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst. Rev. 2012, 9:CD007498.
15. Berg P., Lindhardt B.O. The role of procalcitonin in adult patients with community-acquired pneumonia-a systematic review. Dan. Med. J. 2012, 59(3):A4357.
16. Rea-Neto A., Youssef N.C., Tuche F., Brunkhorst F., Ranieri V.M., Reinhart K., et al. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit. Care 2008, 12(2):R56.
17. Zou M.X., Zhou R.R., Wu W.J., Zhang N.J., Liu W.E., Fan X.G. The use of pleural fluid procalcitonin and C-reactive protein in the diagnosis of parapneumonic pleural effusions: a systemic review and meta-analysis. Am. J. Emerg. Med. 2012, 30(9):1907-1914.
18. Wu M.H., Lin C.C., Huang S.L., Shih H.M., Wang C.C., Lee C.C., et al. Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis. Influenza Other Respir. Viruses 2013, 7(3):349-355.
19. Thompson M., Van den Bruel A., Verbakel J., Lakhanpaul M., Haj-Hassan T., Stevens R., et al. Systematic review and validation of prediction rules for identifying children with serious infections in emergency departments and urgent-access primary care. Health Technol. Assess. 2012, 16(15):1-100.
20. Yo C.H., Hsieh P.S., Lee S.H., Wu J.Y., Chang S.S., Tasi K.C., et al. Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis. Ann. Emerg. Med. 2012, 60(5):591-600.
21. Meem M., Modak J.K., Mortuza R., Morshed M., Islam M.S., Saha S.K. Biomarkers for diagnosis of neonatal infections: a systematic analysis of their potential as a point-of-care diagnostics. J. Glob. Health 2011, 1(2):201-209.
22. Vouloumanou E.K., Plessa E., Karageorgopoulos D.E., Mantadakis E., Falagas M.E. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med. 2011, 37(5):747-762.
23. Dubos F., Korczowski B., Aygun D.A., Martinot A., Prat C., Galetto-Lacour A., et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch. Pediatr. Adolesc. Med. 2008, 162(12):1157-1163.
24. Phillips R.S., Wade R., Lehrnbecher T., Stewart L.A., Sutton A.J. Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Med. 2012, 10:6.
25. Nanda M., Juthani-Mehta M. Novel biomarkers for the diagnosis of urinary tract infection-a systematic review. Biomark. Insights 2009, 4:111-121.
26. Mantadakis E., Plessa E., Vouloumanou E.K., Karageorgopoulos D.E., Chatzimichael A., Falagas M.E. Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies. J. Pediatr. 2009, 155(6):875-881.
27. Leroy S., Romanello C., Galetto-Lacour A., Bouissou F., Fernandez-Lopez A., Smolkin V., et al. Procalcitonin is a predictor for high-grade vesicoureteral reflux in children: meta-analysis of individual patient data. J. Pediatr. 2011, 159(4):644-651.
28. Yu C.W., Juan L.I., Wu M.H., Shen C.J., Wu J.Y., Lee C.C. Systematic review and meta-analysis of the diagnostic accuracy of procalcitonin, C-reactive protein and white blood cell count for suspected acute appendicitis. Br. J. Surg. 2013, 100(3):322-329.
29. Purkayastha S., Chow A., Athanasiou T., Cambaroudis A., Panesar S., Kinross J., et al. Does serum procalcitonin have a role in evaluating the severity of acute pancreatitis? A question revisited. World J. Surg. 2006, 30(9):1713-1721.
30. Mofidi R., Suttie S.A., Patil P.V., Ogston S., Parks R.W. The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review. Surgery 2009, 146(1):72-81.
31. Mann E.A., Wood G.L., Wade C.E. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns 2011, 37(4):549-558.
32. Shen C.J., Wu M.S., Lin K.H., Lin W.L., Chen H.C., Wu J.Y., et al. The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis. Eur. J. Clin. Microbiol. Infect. Dis. 2013, 32(6):807-814.
33. Jones A.E., Fiechtl J.F., Brown M.D., Ballew J.J., Kline J.A. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann. Emerg. Med. 2007, 50(1):34-41.
34. Yu C.W., Juan L.I., Hsu S.C., Chen C.K., Wu C.W., Lee C.C., et al. Role of procalcitonin in the diagnosis of infective endocarditis: a meta-analysis. Am. J. Emerg. Med. 2013, 31(6):935-941.
35. Wu J.Y., Lee S.H., Shen C.J., Hsieh Y.C., Yo P.H., Cheng H.Y., et al. Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: a systematic review and meta-analysis. Arthritis Rheum. 2012, 64(9):3034-3042.
36. Lu X.L., Xiao Z.H., Yang M.Y., Zhu Y.M. Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency: a systematic review and meta-analysis. Nephrol. Dial. Transplant. 2013, 28(1):122-129.
37. Dou Y.H., Du J.K., Liu H.L., Shong X.D. The role of procalcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis. Diagn. Microbiol. Infect. Dis. 2013, 76(4):464-469.
38. Agarwal R., Schwartz D.N. Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. Clin. Infect. Dis. 2011, 53(4):379-387.
39. Matthaiou D.K., Ntani G., Kontogiorgi M., Poulakou G., Armagaanidis A., Dimopoulos G. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med. 2012, 38(6):940-949.
40. Heyland D.K., Johnson A.P., Reynolds S.C., Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation. Crit. Care Med. 2011, 39(7):1792-1799.
41. Kopterides P., Siempos I.I., Tsangaris I., Tsantes A., Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit. Care Med. 2010, 38(11):2229-2241.
42. Soni N.J., Samson D.J., Galaydick J.L., Vats V., Huang E.S., Aronson N., et al. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis. J. Hosp. Med. 2013, 8(9):530-540.
43. Zhang L., Huang J., Xu T., Lin Y. Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. Chin. J. Tuber. Respir. Dis. 2012, 35(4):275-282.
44. Schuetz P., Chiappa V., Briel M., Greenwald J.L. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch. Intern. Med. 2011, 171(15):1322-1331.
45. Li H., Luo Y.F., Blackwell T.S., Xie C.M. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections. Antimicrob. Agents Chemother. 2011, 55(12):5900-5906.
46. Tang H., Huang T., Jing J., Shen H., Cui W. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 2009, 37(6):497-507.
47. Pugh R., Grant C., Cooke R.P., Dempsey G. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. Cochrane Database Syst. Rev. 2011, (10):CD007577.